RSV
RSV (respiratory syncytial virus) is a virus that causes respiratory tract infections.
Products for RSV
- Cat.No. Product Name Information
-
GC62750
(S)-Enzaplatovir
(S)-BTA-C585
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77). -
GC32113
Ac-CoA Synthase Inhibitor1
ACCS2 Inhibitor, MDK6149, VY-3-249
Ac-CoA Synthase Inhibitor1 is a potent, reversible acetate-dependent acetyl-CoA synthetase 2 (ACSS2) inhibitor with an IC50 of 0.6 ?M. -
GC32070
ALS-8112
ALS-8112 is a potent and selective respiratory syncytial virus (RSV) polymerase inhibitor.
-
GN10484
Amentoflavone
Didemethyl Ginkgetin, NSC 295677
-
GC68779
BMS-433771
BMS-433771 is an effective oral respiratory syncytial virus (RSV) inhibitor. It is effective against both A and B groups of RSV, with an EC50 mean value of 20 nM. BMS-433771 can be used for research on respiratory diseases.
-
GC68780
BMS-433771 dihydrochloride hydrate
BMS-433771 dihydrochloride hydrate is an effective inhibitor of respiratory syncytial virus (RSV) with oral activity. It is effective against both group A and B RSV, with an EC50 average of 20 nM. BMS-433771 dihydrochloride hydrate can be used for research on respiratory diseases.
-
GC68883
Clesrovimab
MK1654
Clesrovimab (MK1654) is a fully human monoclonal antibody against respiratory syncytial virus fusion (RSV F) glycoprotein. Clesrovimab has the potential to study respiratory syncytial virus infections.
-
GC43377
Daphnoretin
Daphnoretin is a coumarin that has been found in W.
-
GC69045
EIDD-2749
4'-FlU; 4'-Fluorouridine
EIDD-2749 (4'-Fluorouridine) is an orally effective RdRp inhibitor. It can effectively inhibit the replication of RSV and SARS-CoV-2. EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus (LCMV). EIDD-2749 is a promising oral candidate for COVID-19 research, as well as for other RNA viruses.
-
GC62955
Enzaplatovir
BTA-C585
Enzaplatovir (BTA-C585) is an orally bioavailable fusion inhibitor for respiratory syncytial virus (RSV) infection. -
GC43730
Ganglioside GM1 Asialo Mixture
ASGM1, Asialo GM1, Gangliotetraosylceramide
Ganglioside GM1 asialo is a component of cellular lipid rafts and can be formed by the cleavage of the sialic acid residue from ganglioside GM1 by neuraminidase. -
GC49165
GS-441524 tris-isobutyryl ester
GS-441524 tris-isobutyryl ester
A prodrug form of GS-441524 -
GC70316
JNJ 2408068
JNJ 2408068 is a potent RSV (respiratory syncytial virus) inhibitor.
-
GC32297
JNJ-678 (JNJ-53718678)
JNJ-678; JNJ-53718678
JNJ-678 (JNJ-53718678) (JNJ-678) is a novel fusion protein inhibitor. -
GC71094
JNJ-8003
JNJ-8003 is a potent inhibitor of RSV Polymerase.
-
GC32087
Lumicitabine (ALS-008176)
ALS-008176; ALS-8176
Lumicitabine (ALS-008176) (ALS-008176) is an inhibitor of the respiratory syncytial virus (RSV) polymerase. -
GC68286
Motavizumab
MEDI-524
-
GC69563
Nirsevimab
MEDI8897
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region that extends its half-life. Nirsevimab has an affinity for RSV-B, with a Kd value of 1.5 nM. Nirsevimab can be used in RSV research.
-
GC68300
Palivizumab
MEDI 493
-
GC32300
PC786
PC786 is an inhaled respiratory syncytial virus (RSV) L protein polymerase inhibitor.
-
GC40189
Pentaacetylquercetin
NSC 115919, Peracetylated Quercetin, Quercetin Pentaacetate
Pentaacetylquercetin could interact with F-protein with lower binding energy and better stability to block viral adhesion. -
GC32069
Presatovir (GS-5806)
GS-5806
Presatovir (GS-5806) (GS-5806) is an orally bioavailable RSV fusion inhibitor with a mean EC50 value of 0.43 nM. -
GC32340
RD3-0028
RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM.
-
GC48036
Remdesivir-d4
GS-5734-d4
A neuropeptide with diverse biological activities -
GC11518
Ribavirin
NSC 163039
Ribavirin (ICN-1229) is an antiviral agent against a broad spectrum of viruses including HCV, HIVl, and RSV.
-
GC49395
Ribavirin-13C5
An internal standard for the quantification of ribavirin
-
GC16347
Roflumilast
B 9302107, BY 217, BYK 20869
A PDE4 inhibitor -
GC32213
RSV-IN-1
RSV-IN-1 is a human respiratory syncytical virus (hRSV) inhibitor, with an IC50 of 0.11 μM.
-
GC67684
RSV-IN-7
-
GC19313
RSV604
A-60444
RSV604 is a novel inhibitor of respiratory syncytial virus replication(EC50=0.86 uM); a putative RSV nucleoprotein(N) inhibitor in phase 2 clinical trials. -
GC37565
RSV604 R enantiomer
A-60444 (R enantiomer)
RSV604 R enantiomer is the R-enantiomer of RSV604. -
GC37566
RSV604 racemate
A-60444 racemate
RSV604 (A-60444) racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer. -
GC48973
Sekikaic Acid
A lichen metabolite with diverse biological activities
-
GC62216
Sisunatovir
RV521
Sisunatovir (RV521), an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4 nM and 1.0 nM, respectively. -
GC62217
Sisunatovir hydrochloride
RV521 hydrochloride
Sisunatovir (RV521) hydrochloride, an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4?nM and 1.0?nM, respectively. -
GC69974
Suptavumab
REGN2222
Suptavumab (REGN2222) is a human monoclonal antibody that can bind and block the conserved epitopes on both RSV A and B subtypes. Suptavumab can be used for research on RSV infection.
-
GC17373
TMC353121
TMC353121 is a RSV fusion inhibitor.
-
GC11893
VP-14637
inhibitor of RSV
-
GC38582
Ziresovir
AK0529; RO-0529
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor.